What is Ligandrol?
Ligandrol, also known as LGD-4033, is a synthetic SARM. It is designed to imitate anabolic effects in preclinical trials. These effects range from their impacts on parameters related to muscle hypertrophy, bone health, and adipose tissue reduction in preclinical models. Regarding its mechanism of action, Ligandrol binds to specific androgen receptors in muscle and bone tissues in preclinical models, as observed by researchers. This selective binding differentiates it from traditionally used anabolic steroids. FDA Approval Means
Once a medicine or a drug is approved by the FDA, it has the following meanings:- Safe: The drug or medicine is safe for medical purposes. It does not have severe side effects.
- Effective: It means the drug or a medicine is effective and is ready to give the optimal results.
- High Quality: It means the drug or medicine has been tested for its purity and quality.
Is Ligandrol FDA-approved?
No, Ligandrol has not been approved by the Food and Drug Administration. It is currently on the FDA's prohibited list. This means Ligandrol is not allowed for medical use. Any use of Ligandrol will result in legal proceedings against users. Additionally, the FDA also warns online sources that are selling it under the banner of research supplements. It has also previously banned a few online sources for violating the FDA's laws and regulations.Why Is Ligandrol Not Approved by the FDA?
There are many reasons the FDA does not approve Ligandrol for medical use. Some of the common reasons are mentioned below:- Incompleted Preclinical Trials: This means Ligandrol is still under preclinical trials in the laboratory. According to the recent update on its trials, it has not yet completed all three phases.
- Safety Concerns and Risks in Medical Use: The FDA is concerned about safety and risks in medical use, as it is still in preclinical trials. This thing prevents the FDA from approving it for medical or therapeutic use.
- No Known Long-Term Safety Profile: Researchers lack a long-term safety profile for Ligandrol due to limited investigational trials. No single trial has yet been conducted on humans. Therefore, the FDA raises concerns about its long-term safety profile and lists it on the prohibited list of items.







